Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces its financial results for the year ended 31 December 2024. All figures are in AU$...
Acer Reports January Consolidated Revenues at NT$15.23 Billion, Up 11.7% Year-on-year (YoY), Achieves 7 Months of Consecutive YoY Growth
TAIPEI, Feb. 7, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its January 2024 consolidated revenues at NT$15.23 billion with 11.7% growth year-on-year (YoY), achieving seven months of consecutive YoY growth. Some business highlights for...